Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
small decrease » small increased (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
small decrease » small increased (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
-
1
Differentially expressed genes (DEGs)<sup>a</sup> showing the greatest fold changes from each potato tissue: 10 with greatest increase in expression and 10 with greatest decrease in expression.
Published 2025“…<p>Differentially expressed genes (DEGs)<sup>a</sup> showing the greatest fold changes from each potato tissue: 10 with greatest increase in expression and 10 with greatest decrease in expression.…”
-
2
-
3
DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx
Published 2025“…The latter also quench all types of third-phase transition that occur when classical diluents are used. …”
-
4
Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions....
Published 2025“…In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions. …”
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
19
Factors associated with AL score (multivariable regression analyses for the third follow-up).
Published 2025Subjects: -
20